TRU-SENTIMENT · DeltaNeutral
ACAD Trading Analysis - 09/17/2026 02:30 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $27.37. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $4,302,030 vs put $0. RSI 25.5.
- Symbol
- ACAD
- Price
- $27.37
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-09-17 14:30:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Bullish
Call vs Put dollar volume:
- Call dollar volume: $4,302,030
- Put dollar volume: $0
The pure directional positioning suggests that traders are expecting the stock price to increase in the near term.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 12.35 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 7.26 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment (Source: Company Press Release)
- Analysts raise price targets for ACAD following strong quarterly earnings (Source: Bloomberg)
- ACAD's drug pipeline shows promising results in clinical trials (Source: Reuters)
These headlines suggest a positive outlook for ACAD, with potential catalysts for growth in the near term.
Fundamental Analysis:
Based on the provided fundamentals data:
- Revenue: $11,386,430,000
- Trailing EPS: $2.23
- Trailing P/E: 12.35
- Debt/Equity: 0.33
- Return on Equity (ROE): 29.12%
The company's revenue and EPS indicate a stable financial position. The P/E ratio suggests that the stock may be undervalued compared to its earnings growth. However, the debt/equity ratio and ROE indicate a relatively healthy balance sheet and high profitability.
Current Market Position:
Current price: $27.37
Recent price action: The stock has been trading in a range with a slight downward trend.
Key support and resistance levels:
- Support: $26.64 (recent low)
- Resistance: $28.06 (recent high)
Technical Analysis:
Technical Indicators
SMA trends:
- 5-day SMA: $27.40
- 20-day SMA: $28.49
- 50-day SMA: $27.59
The RSI indicates oversold conditions, while the MACD shows a bearish signal. The 50-day SMA is acting as a support level.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Bullish
Call vs Put dollar volume:
- Call dollar volume: $4,302,030
- Put dollar volume: $0
The pure directional positioning suggests that traders are expecting the stock price to increase in the near term.
Key Price Levels:
25-Day Price Forecast:
ACAD is projected for $27.10 to $28.50
Rationale:
- Based on current SMA trends, RSI momentum, and MACD signals
- Support and resistance levels may act as barriers or targets
Defined Risk Strategy Recommendations:
Based on the projected price range:
- Buy Bull Call Spread: ACAD 261016C00027000 (strike $27.0) and sell ACAD 261016C00028000 (strike $28.0)
- Sell Bear Put Spread: ACAD 261016P00026000 (strike $26.0) and buy ACAD 261016P00025000 (strike $25.0)
- Sell Iron Condor: ACAD 261016C00027000 (strike $27.0), buy ACAD 261016C00028000 (strike $28.0), sell ACAD 261016P00026000 (strike $26.0), and buy ACAD 261016P00025000 (strike $25.0)
Risk Factors:
- Technical warning signs: RSI oversold conditions, bearish MACD signal
- Sentiment divergences: Bullish options flow vs bearish technicals
- Volatility and ATR considerations: Recent price action and 30-day high/low range
Summary & Conviction Level:
Overall bias: Neutral
Conviction level: Medium
One-line trade idea: Traders may consider defined risk strategies based on the projected price range and options flow sentiment.
View ACAD Options Chain